| HOME >> MEDICINE >> TECHNOLOGY |
Current and Future Analysis 109
B. Market Analytics 109
Table 52: Italian Recent Past, Current & Future Analysis for
Antibiotics by Product Segment - Penicillin, Cephalosporin,
Macrolides, Quinolones, Carbapenems and Other Antibiotics
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 109
Table 53: Italian Historic Review for Antibiotics by Product
Segment - Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 110
Table 54: Italian 11-Year Perspective for Antibiotics by
Product Segment - Percentage Breakdown of Dollar Sales for
Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart) 111
17d. THE UNITED KINGDOM 112
A. Market Analysis 112
Current And Future Analysis 112
GlaxoSmithKline Plc - A Key Player 112
B. Market Analytics 113
Table 55: UK Recent Past, Current & Future Analysis for
Antibiotics by Product Segment - Penicillin, Cephalosporin,
Macrolides, Quinolones, Carbapenems and Other Antibiotics
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 113
Table 56: UK Historic Review for Antibiotics by Product
Segment - Penicillin, Cephalosporin, acrolides, Quinolones,
Carbapenems and Other Antibiotics Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 114
Table 57: UK 11-Year Perspective for Antibiotics by Product
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |